Repke, DB; Ferguson, WJ; Bates, DK. Psilocin analogs II. Synthesis of 3-[2-(dialkylamino)ethyl]-, 3-[2-(N-methyl-N-alkylamino)ethyl]-, and 3-[2-(cycloalkylamino)ethyl]indol-4-ols. J. Heterocycl. Chem., 1 Jan 1981, 18 (1), 175–179. 368 kB. https://doi.org/10.1002/jhet.5570180131 #11a
McKenna, DJ; Repke, DB; Lo, L; Peroutka, SJ. Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes. Neuropharmacology, 1 Mar 1990, 29 (3), 191–198. 679 kB. https://doi.org/10.1016/0028-3908(90)90001-8
Nichols, DE. Chemistry and structure–activity relationships of psychedelics. In Behavioral Neurobiology of Psychedelic Drugs; Halberstadt, AL; Vollenweider, FX; Nichols, DE, Eds., Springer, 1 Jan 2017; pp 1-43. 2.6 MB. https://doi.org/10.1007/7854_2017_475
4-HO-DBT · 4-Hydroxy-N,N-dibutyltryptamine
4-HO-DTBT · 4-Hydroxy-N,N-di-tert-butyltryptamine
4-HO-DIBT · 4-Hydroxy-N,N-diisobutyltryptamine
5-EtO-DIPT · 5-Ethoxy-N,N-diisopropyltryptamine
5-EtO-DPT · 5-Ethoxy-N,N-dipropyltryptamine
2-Methyl-5-MeO-DIPT · 2-Methyl-5-methoxy-N,N-diisopropyltryptamine
2-Methyl-5-MeO-DPT · 2-Methyl-5-methoxy-N,N-dipropyltryptamine
N-Pentan-3-ylmethyl-5-MeO-NMT · N-Pentan-3-ylmethyl-5-methoxy-N-methyltryptamine
N-[2-(Morpholin-4-yl)ethyl]-1-phenylcyclohexan-1-amine
N,N-Diisobutyltryptamine N-oxide · DIBT N-oxide
1-Methyl-5-MeO-DIPT · 1-Methyl-5-methoxy-N,N-diisopropyltryptamine
5-Octyloxy-T · 5-Octyloxytryptamine